Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Apr;20(4):400-402.
doi: 10.1016/S1473-3099(20)30132-8. Epub 2020 Feb 27.

COVID-19: Combining Antiviral and Anti-Inflammatory Treatments

Affiliations
Free PMC article
Comment

COVID-19: Combining Antiviral and Anti-Inflammatory Treatments

Justin Stebbing et al. Lancet Infect Dis. .
Free PMC article

Comment on

Similar articles

See all similar articles

Cited by 29 articles

See all "Cited by" articles

References

    1. Peiris JSM, Chu CM, Cheng VCC. Clinical progression and viral load in a community outbreak or coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767–1772. - PMC - PubMed
    1. Huang C, Wang Y, Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Richardson P, Griffin I, Tucker C. Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 2020;395:497–506. - PMC - PubMed
    1. Segler MHS, Preuss M, Waller P. Planning chemical syntheses with deep neural networks and symbolic AI. Nature. 2018;555:604–610. - PubMed
    1. Bekerman E, Neveu G, Shulla A. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. J Clin Invest. 2017;127:1338–1352. - PMC - PubMed

Supplementary concepts

Feedback